Следене
Michael Bockmayr
Michael Bockmayr
Няма данни за членство
Потвърден имейл адрес: uke.de
Заглавие
Позовавания
Позовавания
Година
Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma
S Darb-Esfahani, CA Kunze, H Kulbe, J Sehouli, S Wienert, J Lindner, ...
Oncotarget 7 (2), 1486, 2016
2722016
The landscape of metastatic progression patterns across major human cancers
J Budczies, M von Winterfeld, F Klauschen, M Bockmayr, JK Lennerz, ...
Oncotarget 6 (1), 570, 2015
2712015
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning
F Klauschen, KR Müller, A Binder, M Bockmayr, M Hägele, P Seegerer, ...
Seminars in cancer biology 52, 151-157, 2018
1482018
Resolving challenges in deep learning-based analyses of histopathological images using explanation methods
M Hägele, P Seegerer, S Lapuschkin, M Bockmayr, W Samek, ...
Scientific reports 10 (1), 6423, 2020
1392020
Classical pathology and mutational load of breast cancer–integration of two worlds
J Budczies, M Bockmayr, C Denkert, F Klauschen, JK Lennerz, B Györffy, ...
The Journal of Pathology: Clinical Research 1 (4), 225-238, 2015
1252015
Morphological and molecular breast cancer profiling through explainable machine learning
A Binder, M Bockmayr, M Hägele, S Wienert, D Heim, K Hellweg, M Ishii, ...
Nature Machine Intelligence 3 (4), 355-366, 2021
1062021
Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases
P Jurmeister, M Bockmayr, P Seegerer, T Bockmayr, D Treue, ...
Science Translational Medicine 11 (509), eaaw8513, 2019
1042019
Pan‐cancer analysis of copy number changes in programmed death‐ligand 1 (PD‐L1, CD274)–associations with gene expression, mutational load, and survival
J Budczies, M Bockmayr, C Denkert, F Klauschen, S Gröschel, ...
Genes, Chromosomes and Cancer 55 (8), 626-639, 2016
1002016
Subgroup-specific immune and stromal microenvironment in medulloblastoma
M Bockmayr, M Mohme, F Klauschen, B Winkler, J Budczies, S Rutkowski, ...
Oncoimmunology 7 (9), e1462430, 2018
882018
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
D Holdhof, PD Johann, M Spohn, M Bockmayr, S Safaei, P Joshi, ...
Acta neuropathologica 141, 291-301, 2021
642021
Artificial intelligence and pathology: from principles to practice and future applications in histomorphology and molecular profiling
A Stenzinger, M Alber, M Allgäuer, P Jurmeister, M Bockmayr, J Budczies, ...
Seminars in cancer biology 84, 129-143, 2022
572022
PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcoma
J Budczies, G Mechtersheimer, C Denkert, F Klauschen, SS Mughal, ...
Oncoimmunology 6 (3), e1279777, 2017
572017
Food authentication: Multi-elemental analysis of white asparagus for provenance discrimination
B Richter, S Gurk, D Wagner, M Bockmayr, M Fischer
Food chemistry 286, 475-482, 2019
512019
Multilayered omics-based analysis of a head and neck cancer model of cisplatin resistance reveals intratumoral heterogeneity and treatment-induced clonal selection
F Niehr, T Eder, T Pilz, R Konschak, D Treue, F Klauschen, M Bockmayr, ...
Clinical Cancer Research 24 (1), 158-168, 2018
512018
New network topology approaches reveal differential correlation patterns in breast cancer
M Bockmayr, F Klauschen, B Györffy, C Denkert, J Budczies
BMC systems biology 7, 1-14, 2013
482013
Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan‐cancer survey with implications for the use of immune checkpoint inhibitors
J Budczies, M Bockmayr, F Klauschen, V Endris, S Fröhling, ...
Genes, Chromosomes and Cancer 56 (8), 651-659, 2017
432017
Towards computational fluorescence microscopy: Machine learning-based integrated prediction of morphological and molecular tumor profiles
A Binder, M Bockmayr, M Hägele, S Wienert, D Heim, K Hellweg, ...
arXiv preprint arXiv:1805.11178, 2018
322018
Mutations in genes encoding PI3K‐AKT and MAPK signaling define anogenital papillary hidradenoma
N Pfarr, HP Sinn, F Klauschen, C Flechtenmacher, M Bockmayr, ...
Genes, Chromosomes and Cancer 55 (2), 113-119, 2016
302016
Immunologic profiling of mutational and transcriptional subgroups in pediatric and adult high-grade gliomas
M Bockmayr, F Klauschen, CL Maire, S Rutkowski, M Westphal, ...
Cancer Immunology Research 7 (9), 1401-1411, 2019
28*2019
Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K–AKT pathway
AL Volckmar, J Leichsenring, C Flechtenmacher, N Pfarr, U Siebolts, ...
Genes, Chromosomes and Cancer 56 (1), 11-17, 2017
272017
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20